A team of researchers has developed a new method to calculate and predict how drug molecules in molecular crystals arrange themselves under changing energetic conditions. For pharmaceutical companies, ...

CAMBRIDGE, MA -- About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into tablets ...

Artificial intelligence and machine learning can help overcome poor solubility and bioavailability. Artificial intelligence (AI) and machine learning (ML) in the biopharmaceutical industry have been ...

New and existing technologies, as well as a patient-centric focus, are pushing drug formulation into exciting directions. There are a variety of factors pushing innovation in formulation of drug ...

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...

Formatech, Inc announced the issuance of US patent 7,659,310, entitled 'Methods of Enhancing Solubility of Agents' which covers novel formulation methods to enhance the solubility of certain ...

MOST MAJOR DRUG FIRMS have a horror story in which a crystalline form, or polymorph, of a drug candidate suddenly appears or disappears, to the detriment of the development process. A polymorphic ...

Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion and deterring infringersLOS ANGELES- ...

Chemical engineers have devised a simpler process for incorporating hydrophobic drugs into tablets or other drug formulations, using nanoemulsions. With this method, it may be possible to make many ...